Single-agent high-dose melphalan salvage therapy for Hodgkin's disease: Cost, safety, and long-term efficacy
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/8/12/1277/19480592/8-12-1277.pdf
Reference15 articles.
1. High-dose chemotherapy and autologous bone marrow transplantation for malignant lymphomas;Stahel;Cancer Treat Rev,1995
2. Treatment of advanced Hodgkin's disease with high dose melphalan and autologous bone marrow transplantation;Russell;Bone Marrow Transplant,1989
3. Nonparametric estimation from incomplete estimations;Kaplan;J Am Stat Assoc,1958
4. Regimen-related toxicity in patients undergoing bone marrow transplantation;Bearman;J Clin Oncol,1988
5. The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients;Chopra;Blood,1993
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Saudi lymphoma group's clinical practice guidelines for diagnosis, management and follow-up of patients with various types of lymphoma during the Coronavirus Disease 2019 pandemic;Saudi Journal of Medicine and Medical Sciences;2020
2. Hodgkin's lymphoma: Saudi Lymphoma Group's clinical practice guidelines for diagnosis, management and follow-up;Saudi Journal of Medicine and Medical Sciences;2019
3. Y90-Ibritumomab tiuxetan (Y90-IT) and high-dose melphalan as conditioning regimen before autologous stem cell transplantation for elderly patients with lymphoma in relapse or resistant to chemotherapy: a feasibility trial (SAKK 37/05);Hematological Oncology;2016-09-28
4. Comparative toxicities of 3 platinum-containing chemotherapy regimens in relapsed/refractory lymphoma patients;Hematological Oncology;2016-07-05
5. Relapsed Hodgkin lymphoma in adolescents: focus on current high-dose chemotherapy and autologous stem cell transplant;Clinical Oncology in Adolescents and Young Adults;2014-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3